FDA Cracking Down On Statements Made At Exhibit Booths

In a story appearing today (July 30) in the Wall Street Journal, the Food and Drug Administration is reported to be cracking down on companies whose sales representatives make improper statements about pharmaceutical products at medical conventions.

According to the story, the FDA has cited pharmaceutical firms in at least nine recent cases for allowing representatives to make improper statements or presentations at exhibit booths. Monitoring booth conversations is a new development f

Register to view the full article

Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Already a member? .

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish